Chen, Shuxia <br/><br/>
Effects of Dual-Dose Clopidogrel, Clopidogrel Combined with Tongxinluo Capsule, and Ticagrelor on Patients with Coronary Heart Disease and CYP2C19*2 Gene Mutation After Percutaneous Coronary Interventions (PCI).  [electronic resource] 

 -  Medical science monitor : international medical journal of experimental and clinical research  Aug 2017 
 - 3824-3830 p.  digital 
<br/><br/> Publication Type: Journal Article 
<br/><br/><label>ISSN: </label>1643-3750 
<br/><br/><label>Standard No.: </label>10.12659/msm.903054  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adenosine--analogs & derivatives<br/>Aged<br/>Blood Platelets--drug effects<br/>Clopidogrel<br/>Coronary Disease--drug therapy<br/>Cytochrome P-450 CYP2C19--genetics<br/>Cytochrome P-450 CYP2C19 Inhibitors--pharmacology<br/>Drug Therapy, Combination<br/>Drugs, Chinese Herbal--therapeutic use<br/>Female<br/>Humans<br/>Male<br/>Middle Aged<br/>Mutation<br/>Percutaneous Coronary Intervention--adverse effects<br/>Platelet Aggregation Inhibitors--therapeutic use<br/>Ticagrelor<br/>Ticlopidine--analogs & derivatives